Jan F Nygard
Overview
Explore the profile of Jan F Nygard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
586
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elvatun S, Knoors D, Brant S, Jonasson C, Nygard J
PLOS Digit Health
. 2025 Jan;
4(1):e0000581.
PMID: 39847598
An external control arm based on health registry data can serve as an alternative comparator in single-arm drug development studies that lack a benchmark for comparison to the experimental treatment....
2.
Morgan E, ONeill C, Shah R, Langselius O, Su Y, Frick C, et al.
Breast Cancer Res
. 2024 Nov;
26(1):171.
PMID: 39605105
Background: To assess proportions of metastatic recurrence in women initially diagnosed with non-metastatic breast cancer by stage at diagnosis, breast cancer subtype, calendar period and age. Methods: A systematic search...
3.
Morgan E, ONeill C, Bardot A, Walsh P, Woods R, Gonsalves L, et al.
JCO Glob Oncol
. 2024 Oct;
10:e2400249.
PMID: 39481072
Purpose: Cancer recurrence is an important long-term outcome of cancer survivors that is often not routinely collected and recorded by population-based registries. In this study, we review population-based studies to...
4.
Tisler A, Vork A, Tammemagi M, Ojavee S, Raag M, Savrova A, et al.
Sci Rep
. 2024 Oct;
14(1):24589.
PMID: 39426992
Transitioning to an individualized risk-based approach can significantly enhance cervical cancer screening programs. We aimed to derive and internally validate a prediction model for assessing the risk of cervical intraepithelial...
5.
Larsen M, Olstad C, Lee C, Hovda T, Hoff S, Martiniussen M, et al.
Radiol Artif Intell
. 2024 Apr;
6(3):e230375.
PMID: 38597784
Purpose To explore the stand-alone breast cancer detection performance, at different risk score thresholds, of a commercially available artificial intelligence (AI) system. Materials and Methods This retrospective study included information...
6.
Vallevik V, Babic A, Marshall S, Elvatun S, Brogger H, Alagaratnam S, et al.
Int J Med Inform
. 2024 Mar;
185:105413.
PMID: 38493547
Background: Ensuring safe adoption of AI tools in healthcare hinges on access to sufficient data for training, testing and validation. Synthetic data has been suggested in response to privacy concerns...
7.
Elvatun S, Knoors D, Nygard M, Uuskula A, Vork A, Nygard J
Int J Med Inform
. 2023 Nov;
181:105297.
PMID: 38016404
Background: Cervical cancer is a preventable disease, despite being one of the most common types of female cancers worldwide. Integrating existing programs for cervical cancer screening with personalized risk prediction...
8.
Eijkelboom A, de Munck L, Larsen M, Bijlsma M, Tjan-Heijnen V, van Gils C, et al.
Cancer Epidemiol
. 2023 Oct;
87:102481.
PMID: 37897970
Background: Comparing the impact of the COVID-19 pandemic on the incidence of newly diagnosed breast tumors and their tumor stage between the Netherlands and Norway will help us understand the...
9.
Eijkelboom A, Larsen M, Siesling S, Nygard J, Hofvind S, de Munck L
Prev Med
. 2023 Oct;
175:107723.
PMID: 37820746
Objective: During the COVID-19 pandemic Norway had to suspend its national breast cancer screening program. We aimed to investigate the effect of the pandemic-induced suspension on the screening interval, and...
10.
Hamersma D, Schreuder K, Geleijnse G, Heeg E, Cellamare M, Lobbes M, et al.
Breast Cancer Res Treat
. 2023 Jun;
201(2):247-256.
PMID: 37355527
Purpose: The aim of the study was to benchmark and compare breast cancer care quality indicators (QIs) between Norway and the Netherlands using federated analytics preventing transfer of patient-level data....